• Hospitals

AbbVie and Eisai Announce Fully Human Anti-TNF-alpha Monoclonal Antibody HUMIRA is the First in Japan to be Approved for the Treatment of Hidradenitis Suppurativa

New Delhi, February 22, 2019: (JCN Newswire) – AbbVie, a research-based global biopharmaceutical company and Eisai Co., Ltd. announced that they…